| Cornelis A Rietmeijer, MD | |
|
777 Bannock St, Mc 7782, Denver, CO 80204-4507 | |
| (303) 436-6000 | |
| Not Available |
| Full Name | Cornelis A Rietmeijer |
|---|---|
| Gender | Male |
| Speciality | Preventive Medicine - Public Health & General Preventive Medicine |
| Location | 777 Bannock St, Denver, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689784100 | NPI | - | NPPES |
| 01311059 | Medicaid | CO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083P0901X | Preventive Medicine - Public Health & General Preventive Medicine | 31105 (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Cornelis A Rietmeijer, MD 777 Bannock St, Mc 7782, Denver, CO 80204-4507 Ph: () - | Cornelis A Rietmeijer, MD 777 Bannock St, Mc 7782, Denver, CO 80204-4507 Ph: (303) 436-6000 |
News Archive
Individuals who had cancer as a child may be at increased risk of being obese due to the therapies they received during their youth. The finding comes from a new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society. The study's results suggest the need for effective counseling and weight loss interventions for certain childhood cancer survivors.
Affymetrix, Inc. and Signature Diagnostics AG today announced that they have signed a Powered by Affymetrix™ (PbA) agreement. Under the agreement, Signature Dx obtains a worldwide license to use Affymetrix® microarray technology to develop and commercialize diagnostic and prognostic colorectal cancer (CRC) tests.
Better heart health, as measured by the American Heart Association's Life's Simple 7 (LS7) scale, was associated with a significantly lower risk of developing high blood pressure (also known as hypertension) in middle-aged, Black and white adults, according to new research published today in the Journal of the American Heart Association, an open access journal of the American Heart Association.
Genzyme Corporation announced results today from its CLASSIC I phase 3 trial comparing Clolar® (clofarabine) in combination with the chemotherapy agent cytarabine (ara-c) to cytarabine plus placebo in relapsed-refractory adult acute myeloid leukemia (AML).
› Verified 5 days ago
Alice Boudreau, Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 860 Steele St, Denver, CO 80206 Phone: 303-236-5945 Fax: 303-236-6072 | |
Glenn D Petersen, PA-C Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 1212 S Broadway, Suite 150, Denver, CO 80210 Phone: 615-778-4066 | |
Stephen E Danahey, M.D. Preventive Medicine Medicare: Accepting Medicare Assignments Practice Location: 1212 S Broadway, Suite 150, Denver, CO 80210 Phone: 615-778-4066 | |
Albert P Hattem, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 6750 E Stapleton Dr S, Denver, CO 80216 Phone: 615-778-4066 | |
Mrs. Sally S Foland, RN Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 10065 E Harvard Ave, Suite 250, Denver, CO 80231 Phone: 303-614-1041 | |
John Jeffrey Raschbacher, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 2490 W 26th Ave, Bldg A-300, Denver, CO 80211 Phone: 303-831-9393 Fax: 303-831-6335 | |
Amy L Halvorson Bayer, MPR RD CDE Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 10065 E Harvard Ave, Denver, CO 80231 Phone: 303-743-5855 |